Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

CWD Answers

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
Donate to CWD
Search for:
Contact Us

Archives

Research News

advertisement

January 27, 2016

Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice. See also Potential diabetes treatment advances and No more insulin injections?
The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
Effect of Vitamins C and E on Endothelial Function in Type 1 Diabetes Mellitus. Free full text available in HTML and PDF formats.
Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.
Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins.
Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals.

January 20, 2016

Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.

January 13, 2016

Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.
The role of the intestinal microbiota in type 1 diabetes mellitus.
Severe epidermal nerve fiber loss in diabetic neuropathy is not reversed by long-term normoglycemia after simultaneous pancreas and kidney transplantation.
Retinal Neuronal and Vascular Function in Type 1 Diabetes Adults during Glycaemic Clamps.
The Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies.

January 6, 2016

The role of the intestinal microbiota in type 1 diabetes mellitus.
Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.
Impaired Awareness of Hypoglycemia in Adults With Type 1 Diabetes Is Not Associated With Autonomic Dysfunction or Peripheral Neuropathy.
Use of genetically-engineered pig donors in islet transplantation. Free full text available in HTML and PDF formats.
Human pancreatic beta-like cells converted from fibroblasts. See also Insulin-producing pancreatic cells created from human skin cells.
Combination Stem-Cell Transplant May Benefit Type 1 Diabetes. Free Medscape membership required.

December 30, 2015

Serum 25-Hydroxyvitamin D Concentrations in Children Progressing to Autoimmunity and Clinical Type 1 Diabetes.
Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis.
Genetic and environmental factors affect the onset of type 1 diabetes mellitus.
Insulin knockout mice have extended survival but volatile blood glucose levels on leptin therapy.

December 23, 2015

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
The artificial pancreas: challenges and opportunities. Free full text available in PDF format.
Toward Automation of Insulin Delivery – Management Solutions for Type 1 Diabetes.
Islet Transplantation in Pediatric Patients: Current Indications and Future Perspectives.
The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.
Early Neurodegeneration of the Inner Retinal Layers in Type 1 Diabetes Mellitus.
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes.

December 16, 2015

Therapies to Preserve β-Cell Function in Type 1 Diabetes.
Pancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence Review. Free full text available in HTML and PDF formats.
Evidence of Extrapancreatic Glucagon Secretion in Man.

December 9, 2015

Infant Growth and Risk of Childhood-Onset Type 1 Diabetes in Children From 2 Scandinavian Birth Cohorts See also Weight Gain in Infancy and Type 1 Diabetes Might Be Related.
Reduced β-cell function in early preclinical type 1 diabetes.
Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.
Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.
Substantial proportion of MODY among multiplex families participating in a Type 1 diabetes prediction programme.
Saxagliptin co-therapy in C-peptide-negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia.

December 1, 2015

Type 1 diabetes immunotherapy using polyclonal regulatory T cells. See also End of daily injections for diabetes as scientists restore insulin production.
Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes.
The impact of having siblings – analysis of “hygiene theory” of chronic diseases in patients with type 1 diabetes in population of the Lodz region.
Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes.
A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.
Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.
Diabetic pancreas cells made to produce insulin by bone protein.

November 25, 2015

Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. Free full text available in HTML and PDF (via link) formats.
Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.
Bacillus Calmette-Gu�rin (BCG) Vaccination in Infancy and Risk of Childhood Diabetes.
Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
Metabolic Control With the Bio-inspired Artificial Pancreas in Adults With Type 1 Diabetes: A 24-Hour Randomized Controlled Crossover Study.
Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation.
Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice. Free full text available in HTML and PDF formats.

« Previous
1
…
36
37
38
39
40
…
94
Next »

advertisement

Last Updated: Thursday, June 12, 2025 09:12:22 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Email
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Email
This field is for validation purposes and should be left unchanged.